Exponential Genomics

Exponential Genomics

Biotechnology, 1 Broadway, Cambridge, , 2142, Massachusetts, United States, 1-10 Employees

xenomics.com

  • LinkedIn

phone no Phone Number: +13*********

Who is EXPONENTIAL GENOMICS

Exponential Genomics (Xenomics) is building next-generation life science companies focused on combating the worlds greatest challengesfeeding, fueling, and healing humanity. Built by a te...

Read More

map
  • 1 Broadway, Cambridge, Massachusetts, 2142, United States Headquarters: 1 Broadway, Cambridge, Massachusetts, 2142, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from EXPONENTIAL GENOMICS

Exponential Genomics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Exponential Genomics

Answer: Exponential Genomics's headquarters are located at 1 Broadway, Cambridge, , 2142, Massachusetts, United States

Answer: Exponential Genomics's phone number is +13*********

Answer: Exponential Genomics's official website is https://xenomics.com

Answer: Exponential Genomics's revenue is $25 Million to $50 Million

Answer: Exponential Genomics's SIC: 2836

Answer: Exponential Genomics's NAICS: 325414

Answer: Exponential Genomics has 1-10 employees

Answer: Exponential Genomics is in Biotechnology

Answer: Exponential Genomics contact info: Phone number: +13********* Website: https://xenomics.com

Answer: Exponential Genomics (Xenomics) is building next-generation life science companies focused on combating the worlds greatest challengesfeeding, fueling, and healing humanity. Built by a team of scientists trained at Harvard and MIT, our core technology is a novel gene-editing technique capable of performing over 400 years of CRISPR in 8 weeks. Our Xenoarray technology is well-positioned to revolutionize gene editing techniques by enabling gene knock-ins of up to 8,000 base pairs or 8 unique genes. We anticipate obtaining at least 3,000 unique cell lines from each experiment, which could radically streamline the process of integrating parallel workflows in bioengineering. Exponentials current commercialization projects include streamlining the manufacturing of biopharmaceuticals, vaccines, human breastmilk, cell therapies, cultured meats & dairy, water desalination, carbon recycling, cannabinoids, psychedelics, food flavors, and perfume scents.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access